AzTrials
AzTrials

Univentricular HeartNCT05617534

Impact of Exercise Training on Single Ventricle Function in Paediatric Fontan Patients

An observational study of Univentricular Heart, run by Children's Health Ireland at 1 site in Ireland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this observational study is to learn about how a prescribed Exercise Training Program would affect children living with a Fontan circulation. From birth, the children who are born with single functioning ventricle will undergo 3-staged Fontan surgery to achieve a unique Fontan circulation, supported by one… Read more about this study

Who is it for?
Ages 8 to 18 years
Conditions the study is for
Univentricular Heart
How many people
30 participants
Where
1 siteIreland
Study dates
10 Jan 2023to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 18 years
  • All sexes
  • Child, Adult

Study population: Children aged 8 to 18 years old, who are living with a Fontan circulation, who have met the eligibility criteria listed above.

Who may be able to join

  • Patients with Fontan circulation, age range 8 to 18 years
  • Ability to perform a cardiopulmonary exercise stress test (CPET)
  • Free from acute or chronic respiratory illness and/or conditions that might affect exercise performance
  • Who have had a Fontan operation at least six months prior.

Who cannot join

  • Existing neuro-disability i.e. with paresis post cerebrovascular accident
  • Neurodevelopmental issue with inability to comply with commands.
  • Documented life-threatening arrhythmia without implantable cardioverter defibrillator
  • Moderate or severe atrio-ventricular valve regurgitation
  • Moderate or severe ventricular dysfunction by echocardiography exams
  • Acute inflammatory cardiac disease
Show all 11Show fewer
  • documented coronary artery stenosis and/or myocardial ischaemia
  • Heart failure requiring hospitalisation in the past year
  • Evidence of systemic venous pathway obstruction by echocardiography or catheterisation
  • Resting oxygen saturation < 90%
  • Systemic ventricular outflow tract stenosis with peak resting systolic gradient > 50mmHg

Trial locations and contacts

1 site in 1 country.

Li Yen Ng, MB BCh BAO contact

+353862341835

ngliyen@gmail.com

Adam James, MD contact

+353871925275

adamoj@gmail.com

Ireland1 site
  • Children's Health Ireland

    Dublin, D12 N512

    Li Yen Ng, MB BCh BAO, +353862341835, ngliyen@gmail.com

    Adam James, MD, +353871925275, adamoj@gmail.com

Other trials in Ireland

About this study

Official title: A Single-centre, Prospective Case Control Study Evaluating the Impact of a Standardised Aerobic and Strength Exercise Regime on Exercise Capacity, Ventricular Function, and Perceived Quality of Life in Paediatric Fontan Patients

The goal of this observational study is to learn about how a prescribed Exercise Training Program would affect children living with a Fontan circulation.

From birth, the children who are born with single functioning ventricle will undergo 3-staged Fontan surgery to achieve a unique Fontan circulation, supported by one functioning ventricle. With advancement in surgical technique and medical care, there are increasing number of children living with Fontan circulating surviving into adulthood.

Read more

A significant number of these individuals develop complications in their adulthood due to problems related to this unique circulation, including reduced exercise tolerance, heart failure, abnormal heart rhythm or premature death. Many of these children have acquired sedentary lifestyle, and may have lower self-perceived health related quality of life.

Exercise training is a well-established therapy used in adult population with heart failure. It has been shown to be safe in children with congenital heart disease and with Fontan circulation, it improves their aerobic exercise capacity which is associated with better outcomes.

The main question[s] it aims to answer are the impact of a Exercise Training program on:

  1. Single ventricle function
  2. Exercise capacity
  3. Self-perceived quality of life
  4. Skeletal muscle mass

Participants will be given a 20-weeks exercise program, 3 sessions of 30 minutes workout weekly, to carry out at home. The following tests will be performed prior to starting and upon completion of the exercise program:

  • Echocardiogram
  • Cardiopulmonary exercise test
  • Body composition scan using a bio-impedance analyser
  • Quality of life questionnaires
Keywords
Fontan, Exercise Training, Ventricular Function, Quality of Life
Medical subject headings
Univentricular Heart

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Single ventricle Function

    By implementing a prescribed exercise training regime over a 20 week period, a change will be noted in ventricular function at the subclinical state using Echocardiography parameters.

    Measured: After a 20 week Exercise training program

Secondary outcomes (4)
  1. Exercise Capacity

    By implementing a prescribed exercise training regime over a 20 week period, an improvement will be noted in functional exercise capacity, which will be objectively assessed using cardiopulmonary exercise test.

    Measured: After a 20 week Exercise training program

  2. Self-perceived Quality of life - Generic

    By implementing a prescribed exercise training regime over a 20 week period, an improvement will be noted in self-reported quality of life, which will be assessed using validated QOL questionnaire - Using Paediatric Quality of Life Inventory, PedsQL v4.0

    Measured: After a 20 week Exercise training program

  3. Self-perceived Quality of life - Cardiac module

    By implementing a prescribed exercise training regime over a 20 week period, an improvement will be noted in self-reported quality of life, which will be assessed using validated QOL questionnaire - Using PedsQL Cardiac Module v3.0

    Measured: After a 20 week Exercise training program

  4. Skeletal muscle mass

    By implementing a prescribed exercise training regime over a 20 week period, an improvement will be noted in the skeletal muscle mass, which will be assessed using a non-invasive bio-impedance analyser.

    Measured: After a 20 week Exercise training program

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Nov 2022
  2. Study start10 Jan 2023 (estimated)
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05617534
Sponsor's protocol ID
RSFG-21-ACC13
Status last verified
Dec 2022
First submitted
24 Oct 2022
Last updated
21 Dec 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Univentricular Heart, run by Children's Health Ireland at 1 site in Ireland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Li Yen Ng, MB BCh BAO (+353862341835, ngliyen@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Single ventricle Function (time frame: After a 20 week Exercise training program). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Dec 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in